Xiaoyan Li

ALSUntangled #67: rituximab

Gary L. Pattee, J. Glass, M. Benatar, 2022, Amyotrophic lateral sclerosis & frontotemporal degeneration.

An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis

R. Bedlack, Yuyao Sun, Xiaoyan Li, 2023, Expert review of neurotherapeutics.

ALSUntangled #70: caffeine

Gary L. Pattee, M. Benatar, M. Bromberg, 2023, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral Sclerosis

R. Bedlack, D. Koeberl, M. Lutz, 2023, Journal of clinical neuromuscular disease.

ALSUntangled #71: Nuedexta

Gary L. Pattee, M. Benatar, M. Bromberg, 2023, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis

R. Bedlack, Xiaoyan Li, 2024, Expert opinion on emerging drugs.